EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY 4.0

Investigating the impact of added Profhilo mesogel to subcision versus subcision monotherapy in treating acne scars; a single‐blinded, split‐face randomized trial

Mani Dastgheib iD, Sama Heidari iD, Arghavan Azizipour iD, Mohammadreza Kavyani iD, Vahide Lajevardi iD, Amir Hooshang Ehsani iD, Amir Teimourpour iD, Maryam Daneshpazhooh iD, Mansour Nassiri Kashani iD, Kamran Balighi iD

Journal of Cosmetic Dermatology · 2024

DOI: 10.1111/jocd.16258 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von Mani Dastgheib und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Acne Vulgaris, Cicatrix, Hyaluronic Acid, Patient Satisfaction. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tehran University of Medical Sciences and Health Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acne scar is an inflammatory condition, which commonly occurs in patients with acne vulgaris, especially in adults. Mesogels have been reported effective in improving atrophic acne scars.

Aims

We investigated the efficacy of adding Profhilo (a hyaluronic acid‐based filler) to subcision as a new treatment method.

Methods

Twelve patients aged 18–45 years with atrophic acne scars on both sides of the face participated in this single‐blinded, split‐face, randomized controlled trial. Each side of the face was randomly assigned to one of the treatment methods, including subcision alone and subcision + Profhilo. Patients in the Profhilo arm received mesogel (1 cc) in addition to the subcision procedure. Both methods were carried out two times at 1‐month intervals. Assessments were done based on the sonographic depth of scars, and two blinded observers examined photographs at baseline and 3 months after the final session and the results were reported based on an exclusively made formula as the total score. The Global Improvement Scale and Visual Analogue Scale (VAS) (for patient satisfaction) were also used.

Results

The VAS score of patient satisfaction was statistically significant in the Profhilo arm, with a mean improvement of 528.08 and 219.06 in the subcision arm ( p = 0.02). No significant difference was seen in total acne scar reduction comparing the two methods (29.74 in the Profhilo arm and 22.27 in the subcision arm, p = 0.56). Sonographic depth reduction was also non‐significant, with a mean of 29.21 in the Profhilo arm and 28.53 in the subcision arm ( p = 0.4). The mean global improvement was reported as four in both arms, and no statistical significance was observed ( p = 0.89). The best response to treatment belonged to the rolling subtype in both methods ( p = 0.029 for the Profhilo arm and p = 0.001 for the subcision arm).

Conclusion

Despite no significant difference between the methods, Profhilo is more effective due to a higher satisfaction rate and better physiologic effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acne VulgarisCicatrixHyaluronic AcidPatient SatisfactionDermal FillersHumansSingle-Blind MethodAdultFemaleYoung AdultMaleTreatment OutcomeAdolescentMiddle AgedCombined Modality TherapyFaceCosmetic Techniques

Stichwörter der Autor:innen

Profhiloacne scarmesogel fillerssubcision

Substanzen

Hyaluronic AcidDermal Fillers

Autor:innen und Institutionen

  • Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Mani Dastgheib, Sama Heidari, Arghavan Azizipour, Mohammadreza Kavyani, Vahide Lajevardi, Amir Hooshang Ehsani, Amir Teimourpour, Maryam Daneshpazhooh, Mansour Nassiri Kashani, Kamran Balighi

Förderung

  • Tehran University of Medical Sciences and Health Services

Zitieren

APA

Dastgheib, M., Heidari, S., Azizipour, A., Kavyani, M., Lajevardi, V., Ehsani, A. H., Teimourpour, A., Daneshpazhooh, M., Kashani, M. N., & Balighi, K. (2024). Investigating the impact of added Profhilo mesogel to subcision versus subcision monotherapy in treating acne scars; a single‐blinded, split‐face randomized trial. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16258

Vancouver

Dastgheib M, Heidari S, Azizipour A, Kavyani M, Lajevardi V, Ehsani AH, et al. Investigating the impact of added Profhilo mesogel to subcision versus subcision monotherapy in treating acne scars; a single‐blinded, split‐face randomized trial. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.16258

BibTeX
@article{Dastgheib2024,
  author = {Dastgheib, Mani and Heidari, Sama and Azizipour, Arghavan and Kavyani, Mohammadreza and Lajevardi, Vahide and Ehsani, Amir Hooshang and Teimourpour, Amir and Daneshpazhooh, Maryam and Kashani, Mansour Nassiri and Balighi, Kamran},
  title = {Investigating the impact of added Profhilo mesogel to subcision versus subcision monotherapy in treating acne scars; a single‐blinded, split‐face randomized trial},
  journal = {Journal of Cosmetic Dermatology},
  year = {2024},
  doi = {10.1111/jocd.16258}
}
Kostenlos starten →